Greig NH, Mattson MP, Perry T, Chan SL, Giordano T, Sambamurti K, Rogers JT, Ovadia H, Lahiri DK (2004) New therapeutic strategies and drug candidates for neurodegenerative diseases: p53 and TNF-alpha inhibitors, and GLP-1 receptor agonists
These effects support both internal connective tissue health and visible refinement of skin structure and tone
Available as an injection, the medication interacts with your body's own hormones to suppress appetite and enhance calorie burning
Retrieved 2009-02-02
By engaging both pathways, these medications may influence hunger signals, feelings of fullness, and the body's response to glucose